
Sabiha Naim Qazi
Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1356899
[patent_doc_number] => 06569413
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Hair fixative composition containing an anionic polymer'
[patent_app_type] => B1
[patent_app_number] => 09/833364
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5410
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09833364
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/833364 | Hair fixative composition containing an anionic polymer | Apr 11, 2001 | Issued |
Array
(
[id] => 6822152
[patent_doc_number] => 20030220313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy'
[patent_app_type] => new
[patent_app_number] => 10/257081
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5264
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257081 | Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy | Apr 11, 2001 | Issued |
Array
(
[id] => 6880472
[patent_doc_number] => 20010031759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases'
[patent_app_type] => new
[patent_app_number] => 09/827009
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26429
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031759.pdf
[firstpage_image] =>[orig_patent_app_number] => 09827009
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/827009 | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases | Apr 4, 2001 | Issued |
| 09/720756 | Prophylactic treatments of neovascularisation in macular degeneration | Apr 4, 2001 | Abandoned |
Array
(
[id] => 6892297
[patent_doc_number] => 20010018459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Pentacyclic triterpenes'
[patent_app_type] => new
[patent_app_number] => 09/822478
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5781
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018459.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822478
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822478 | Pentacyclic triterpenes | Apr 1, 2001 | Issued |
Array
(
[id] => 6921769
[patent_doc_number] => 20010029254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Pentacyclic triterpenes'
[patent_app_type] => new
[patent_app_number] => 09/822479
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5839
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029254.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822479 | Pentacyclic triterpenes | Apr 1, 2001 | Issued |
| 09/787553 | Compounds for medical treatment | Mar 19, 2001 | Abandoned |
Array
(
[id] => 1280097
[patent_doc_number] => 06646143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-11
[patent_title] => 'Vitamin D analogues'
[patent_app_type] => B2
[patent_app_number] => 09/787664
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7670
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/646/06646143.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787664
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787664 | Vitamin D analogues | Mar 19, 2001 | Issued |
Array
(
[id] => 1387211
[patent_doc_number] => 06540987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-01
[patent_title] => 'Polyesters based on hydroxy fatty acids and lower hydroxy alkyl acids and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 09/805894
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9640
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/540/06540987.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805894
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805894 | Polyesters based on hydroxy fatty acids and lower hydroxy alkyl acids and uses thereof | Mar 14, 2001 | Issued |
Array
(
[id] => 1417893
[patent_doc_number] => 06518275
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Fungicidal mixtures'
[patent_app_type] => B1
[patent_app_number] => 09/809512
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9110
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518275.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809512
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809512 | Fungicidal mixtures | Mar 14, 2001 | Issued |
Array
(
[id] => 6887950
[patent_doc_number] => 20010008944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-19
[patent_title] => 'Method for preparing cycloheptimidazoles'
[patent_app_type] => new-utility
[patent_app_number] => 09/805516
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1782
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20010008944.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805516
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805516 | Method for preparing cycloheptimidazoles | Mar 13, 2001 | Issued |
Array
(
[id] => 6344013
[patent_doc_number] => 20020035098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Agents and methods for the prevention of initial onset and recurrence of existing cancers'
[patent_app_type] => new
[patent_app_number] => 09/808408
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3336
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035098.pdf
[firstpage_image] =>[orig_patent_app_number] => 09808408
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/808408 | Agents and methods for the prevention of initial onset and recurrence of existing cancers | Mar 13, 2001 | Abandoned |
Array
(
[id] => 1134849
[patent_doc_number] => 06784170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-31
[patent_title] => 'Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one'
[patent_app_type] => B2
[patent_app_number] => 09/780990
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15331
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/784/06784170.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780990
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780990 | Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one | Feb 8, 2001 | Issued |
Array
(
[id] => 779410
[patent_doc_number] => 06995278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-07
[patent_title] => 'Antiangiogenic agents'
[patent_app_type] => utility
[patent_app_number] => 09/779331
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11320
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/995/06995278.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779331
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779331 | Antiangiogenic agents | Feb 7, 2001 | Issued |
Array
(
[id] => 1501670
[patent_doc_number] => 06486332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-26
[patent_title] => 'Fluorescent pigments'
[patent_app_type] => B2
[patent_app_number] => 09/778324
[patent_app_country] => US
[patent_app_date] => 2001-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4306
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/486/06486332.pdf
[firstpage_image] =>[orig_patent_app_number] => 09778324
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/778324 | Fluorescent pigments | Feb 5, 2001 | Issued |
| 09/601225 | Serine carbonates | Feb 1, 2001 | Abandoned |
Array
(
[id] => 1373431
[patent_doc_number] => 06562805
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Cosalane compounds and methods for their use'
[patent_app_type] => B1
[patent_app_number] => 09/771769
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8278
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 403
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562805.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771769
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771769 | Cosalane compounds and methods for their use | Jan 28, 2001 | Issued |
Array
(
[id] => 6048707
[patent_doc_number] => 20020169173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Oxazoles for treating cytokine mediated diseases'
[patent_app_type] => new
[patent_app_number] => 09/769096
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16998
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169173.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769096
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769096 | Oxazoles for treating cytokine mediated diseases | Jan 24, 2001 | Abandoned |
Array
(
[id] => 6674823
[patent_doc_number] => 20030060426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Formulation for protection against oxidative stress containing benzofuranone derivatives'
[patent_app_type] => new
[patent_app_number] => 10/182385
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15786
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182385 | Formulation comprising benzofuranone derivatives for protection against oxidative stress | Jan 21, 2001 | Issued |
Array
(
[id] => 6893823
[patent_doc_number] => 20010016189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Stable, aqueous cationic hydrogel'
[patent_app_type] => new
[patent_app_number] => 09/781505
[patent_app_country] => US
[patent_app_date] => 2001-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2185
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016189.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781505
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781505 | Stable, aqueous cationic hydrogel | Jan 11, 2001 | Issued |